We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
REFERENCES
1
1.O'Reardon, JRFontecha, JF, Cristancho, MA, Newman, S. Unexpected reduction in migraine and psychogenic headaches following rTMS treatment for major depression: A report of two cases. CNS Spectr. 2007;12:921–925.Google Scholar
2
2.The International Classification of Headache Disorders. 2nd ed (ICHD-II). Cephalalgia. 2004;24(suppl 1):1–160.Google Scholar
3
3.Tfelt-Hansen, P, Block, G. Dahlöf, C, et al.International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20:765–786.Google Scholar
4
4.Obermann, M. Katsarava, Z. Management of medication-overuse headache. Expert Rev Neurotherapeutics. 2007;7:1145–1155.Google Scholar
5
5.O'Reardon, JP, Solvason, HB, Janicak, PG, et al.Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208–1216.Google Scholar
6
6.Lipton, RB, Bigal, ME, Diamond, M, et al.AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–349.Google Scholar
7
7.Radat, F, Swendsen, J. Psychiatric comorbidity in migraine: a review. Cephalalgia. 2005:25:165–178.CrossRefGoogle ScholarPubMed
8
8.Mitsikostas, DD, Thomas, AM. Comorbidity of headache and depressive disorders. Cephalalgia. 1999;19:211–217.Google Scholar
9
9.Brighina, F, Piazza, A, Vitello, G, et al.rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci. 2004;227:67–71.Google Scholar
10
10.Fumal, A, Coppola, G, Bohotin, V, et al.Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients. Cephalalgia. 2006;26:143–149.Google Scholar
12.Mohammad, YM, Kothari, R, Hughes, G, et al.Transcranial magnetic stimulation (TMS) relieves migraine headache. Platform presentation at the American Headache Society annual scientific meeting in Los Angeles, 06 23, 2006.Google Scholar
13
13.Belmaker, B, Fitzgerald, P, George, MS, et al.Managing the risks of repetitive transcranial stimulation. CNS Spectr. 2003;8:489.Google Scholar
14
14.Schoenen, J, Bolla, M. Migraine and epilepsy. Two of a kind?K-Opinions. 2007;3:2–5.Google Scholar
1
1.O'Reardon, JP, Fontecha, JRCristancho, MA, Newman, S. Unexpected reduction in migraine and psychogenic headaches following rTMS treatment for major depression: a report of two cases. CNS Spectr. 2007;12:921–925.CrossRefGoogle ScholarPubMed